DVA DaVita Inc. Common Stock
$177,22
Cena · Sie 20, 2026
Dane fundamentalne na dzień Sie 4, 2026
Zakres 52 tyg.
$101–$247
52% of range
Ocena Analityków
HOLD
13 analysts
Cena Docelowa
$218
+23% upside
P/E (TTM)
18.2
ROE
-281.8%
Marża Zysku Netto
5.5%
O DaVita Inc. Common Stock Przegląd firmy z Wikipedii
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Czytaj więcej
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
Acquisitions and divestments
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
Legal issues
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
DVA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$177.22
Kapitalizacja Rynkowa
$12.26B
P/E (TTM)
18.2
EPS (TTM)
$9.84
Przychody (TTM)
$13.64B
Stopa dywidendy
0.00%
ROE
-281.8%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$101 – $247
DVA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$13.64B
2016-12-31
→
2025-12-31
EPS
$9.84
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$1.31B
2016-12-31
→
2025-12-31
Marże
5.5%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
DVA
Mediana porównawcza
P/E (TTM)
18.2
32.6
P/S (TTM)
0.9
2.0
P/B
-18.8
4.4
Price / FCF (Cena / FCF)
9.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
DVA
Mediana porównawcza
Operating Margin (Marża Operacyjna)
15.0%
—
Net Profit Margin (Marża Zysku Netto)
5.5%
2.4%
ROA
4.3%
4.5%
ROE
-281.8%
10.9%
ROIC
-245.6%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
DVA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
1.3
1.7
Quick Ratio (Wskaźnik Szybkości)
1.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
DVA
Mediana porównawcza
Revenue YoY (Przychody R/R)
6.5%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
5.5%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
3.4%
—
EPS YoY
-8.3%
—
Net Income YoY (Zysk Netto R/R)
-20.2%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
DVA
Mediana porównawcza
Payout Ratio (Wskaźnik Wypłaty Dywidendy)
0.00%
—
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
0.00%
Wskaźnik Wypłaty Dywidendy
0.00%
CAGR dywidendy 5-letni
—
DVA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
TRZYMAJ
13 analityków
- Mocne kupno 1 7,7%
- Kup 5 38,5%
- Trzymaj 6 46,2%
- Sprzedaj 1 7,7%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
7 analityków · 2026-08-16
Mediana
$220.00
Teraz
$177.22
Niski
$165.00
Wysoki
$270.00
Średni cel
$220.00
+24,1%
Średnia cel
$218.43
+23,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.04%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $4.02 | $3.92 | 0.10% |
| 31 marca 2026 | $2.87 | $2.34 | 0.53% |
| 31 grudnia 2025 | $3.40 | $3.19 | 0.21% |
| 30 września 2025 | $2.04 | $3.25 | -1.2% |
| 30 czerwca 2025 | $2.95 | $2.83 | 0.12% |
| 31 marca 2025 | $2.00 | $1.97 | 0.03% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | -153,159,000 | 72,075,000 | 75,943,000 | 79,368,000 | -173,404,000 | 83,721,000 | 86,899,000 | 87,775,000 | -182,013,000 | 91,322,000 | 90,984,000 | 90,497,000 | -188,967,000 | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | -156,521,000 | 73,769,000 | 77,362,000 | 81,275,000 | -178,018,000 | 85,795,000 | 88,950,000 | 90,547,000 | -186,760,000 | 94,041,000 | 93,418,000 | 92,483,000 | -195,704,000 | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Wycena (TTM) 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.77B | $13.44B | · | $13.29B | $13.05B | $12.74B | · | $12.64B | $12.38B | $12.06B | · | $11.94B | $11.75B | $11.57B | · | $11.63B | |
| Net Income TTM | $813M | $710M | · | $727M | $800M | $840M | · | $924M | $888M | $781M | · | $646M | $624M | $608M | · | $752M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 19.3 | 16.2 | · | 14.6 | 14.9 | 15.9 | · | 16.0 | 14.3 | 16.4 | · | 13.7 | 15.2 | 12.9 | · | 11.2 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.0 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| P / FCF | · | 48.6 | · | · | · | 321.7 | · | · | · | -48.5 | · | · | · | 23.4 | · | · | |
| Earnings Yield | 5.2% | 6.2% | · | 6.9% | 6.7% | 6.3% | · | 6.3% | 7.0% | 6.1% | · | 7.3% | 6.6% | 7.8% | · | 8.9% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Marża Operacyjna % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Zysk netto | $747M | $936M | $692M | $560M | $978M |
| Rozwodniony EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Wskaźnik Szybkości | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 697 emitentów · $7.9B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 126 (-12 vs poprzedni kw.) | 61 (-2 vs poprzedni kw.) | 184 (+11 vs poprzedni kw.) | 225 (+19 vs poprzedni kw.) | -243K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $3 331 328 308 | 14 973 608 | 42,04% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $467 525 034 | 2 101 425 | 5,90% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306 558 307 | 1 377 914 | 3,87% | Akcje |
| STATE STREET CORP | $294 345 267 | 1 323 019 | 3,71% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $235 869 514 | 1 060 183 | 2,98% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $199 315 922 | 896 621 | 2,52% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197 802 963 | 889 082 | 2,50% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $165 824 664 | 746 907 | 2,09% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163 166 832 | 733 400 | 2,06% | Opcja kupna |
| Gates Capital Management, Inc. | $153 096 497 | 688 136 | 1,93% | Akcje |
| BANK OF AMERICA CORP /DE/ | $133 302 007 | 599 164 | 1,68% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81 331 791 | 365 569 | 1,03% | Akcje |
| NORGES BANK | $76 627 007 | 344 422 | 0,97% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $67 404 554 | 305 067 | 0,85% | Akcje |
| GOLDMAN SACHS GROUP INC | $63 752 756 | 286 555 | 0,80% | Akcje |
| D. E. Shaw & Co., Inc. | $62 040 995 | 278 861 | 0,78% | Akcje |
| JANE STREET GROUP, LLC | $53 573 184 | 240 800 | 0,68% | Opcja kupna |
| Holocene Advisors, LP | $52 875 709 | 237 665 | 0,67% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 100 176 | 216 200 | 0,61% | Opcja sprzedaży |
| Quantinno Capital Management LP | $45 366 106 | 203 910 | 0,57% | Akcje |
| CITADEL ADVISORS LLC | $44 465 298 | 199 862 | 0,56% | Akcje |
| CITADEL ADVISORS LLC | $44 184 528 | 198 600 | 0,56% | Opcja kupna |
| VANGUARD FIDUCIARY TRUST CO | $40 134 502 | 180 396 | 0,51% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37 089 700 | 241 328 | 0,47% | Akcje |
| Gotham Asset Management, LLC | $36 393 278 | 163 580 | 0,46% | Akcje |
| JANE STREET GROUP, LLC | $35 774 784 | 160 800 | 0,45% | Opcja sprzedaży |
| Doma Perpetual Capital Management LLC | $35 522 937 | 159 668 | 0,45% | Akcje |
| FIRST TRUST ADVISORS LP | $34 161 205 | 153 548 | 0,43% | Akcje |
| TODD ASSET MANAGEMENT LLC | $32 697 663 | 146 969 | 0,41% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32 011 312 | 143 884 | 0,40% | Akcje |
| Allianz Asset Management GmbH | $30 236 367 | 135 906 | 0,38% | Akcje |
| MORGAN STANLEY | $28 624 054 | 128 659 | 0,36% | Akcje |
| Toroso Investments, LLC | $28 283 664 | 248 954 | 0,36% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $26 480 460 | 119 024 | 0,33% | Akcje |
| BlackRock, Inc. | $26 457 544 | 118 921 | 0,33% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $26 377 896 | 118 563 | 0,33% | Akcje |
| Amundi | $25 967 198 | 116 717 | 0,33% | Akcje |
| BARCLAYS PLC | $25 933 826 | 116 567 | 0,33% | Akcje |
| Davidson Kempner Capital Management LP | $25 162 043 | 113 098 | 0,32% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $23 582 658 | 105 999 | 0,30% | Akcje |
| VANGUARD GROUP INC | $23 117 136 | 203 478 | 0,29% | Akcje |
| RHUMBLINE ADVISERS | $23 076 629 | 103 725 | 0,29% | Akcje |
| Woodline Partners LP | $22 872 501 | 102 807 | 0,29% | Akcje |
| UBS Group AG | $20 846 376 | 93 700 | 0,26% | Opcja sprzedaży |
| MILLENNIUM MANAGEMENT LLC | $20 579 400 | 92 500 | 0,26% | Opcja sprzedaży |
| FMR LLC | $20 183 608 | 90 721 | 0,25% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $19 532 854 | 87 796 | 0,25% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $17 151 873 | 77 094 | 0,22% | Akcje |
| California Public Employees Retirement System | $15 370 253 | 69 086 | 0,19% | Akcje |
| Swiss National Bank | $14 906 160 | 67 000 | 0,19% | Akcje |
| Vanguard Global Advisers, LLC | $14 696 806 | 66 059 | 0,19% | Akcje |
| WOLVERINE TRADING, LLC | $14 482 431 | 110 900 | 0,18% | Opcja sprzedaży |
| National Philanthropic Trust | $14 000 889 | 62 931 | 0,18% | Akcje |
| PineBridge Investments, L.P. | $13 874 153 | 104 419 | 0,18% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $13 325 440 | 59 895 | 0,17% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $13 022 644 | 58 534 | 0,16% | Akcje |
| Candriam S.C.A. | $12 727 615 | 57 263 | 0,16% | Akcje |
| DANSKE BANK A/S | $12 471 116 | 56 055 | 0,16% | Akcje |
| CITADEL ADVISORS LLC | $12 280 896 | 55 200 | 0,15% | Opcja sprzedaży |
| Susquehanna Portfolio Strategies, LLC | $12 219 714 | 54 925 | 0,15% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $11 902 680 | 53 500 | 0,15% | Opcja kupna |
| STOREBRAND ASSET MANAGEMENT AS | $11 500 659 | 51 693 | 0,15% | Akcje |
| LPL Financial LLC | $10 778 934 | 48 449 | 0,14% | Akcje |
| Robeco Institutional Asset Management B.V. | $10 083 684 | 45 324 | 0,13% | Akcje |
| Callahan Advisors, LLC | $10 033 403 | 45 098 | 0,13% | Akcje |
| Assenagon Asset Management S.A. | $9 963 322 | 44 783 | 0,13% | Akcje |
| Verition Fund Management LLC | $9 740 174 | 43 780 | 0,12% | Akcje |
| Prospera Financial Services Inc | $9 482 479 | 42 623 | 0,12% | Akcje |
| Te Ahumairangi Investment Management Ltd | $9 480 318 | 42 612 | 0,12% | Akcje |
| SEI INVESTMENTS CO | $9 251 830 | 41 585 | 0,12% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $9 207 557 | 41 386 | 0,12% | Akcje |
| Inlet Private Wealth, LLC | $9 004 878 | 40 475 | 0,11% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $8 835 126 | 39 712 | 0,11% | Akcje |
| Caisse de depot et placement du Quebec | $8 721 216 | 39 200 | 0,11% | Akcje |
| Twin Tree Management, LP | $8 454 240 | 38 000 | 0,11% | Opcja kupna |
| Brevan Howard Capital Management LP | $8 343 000 | 37 500 | 0,11% | Opcja kupna |
| CITIGROUP INC | $8 298 504 | 37 300 | 0,10% | Opcja sprzedaży |
| NISA INVESTMENT ADVISORS, LLC | $7 947 431 | 35 722 | 0,10% | Akcje |
| IEQ CAPITAL, LLC | $7 900 154 | 35 510 | 0,10% | Akcje |
| UBS Group AG | $7 386 336 | 33 200 | 0,09% | Opcja kupna |
| Counterpoint Mutual Funds LLC | $7 384 111 | 33 190 | 0,09% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $7 170 308 | 32 229 | 0,09% | Akcje |
| FIFTH THIRD BANCORP | $7 074 159 | 31 797 | 0,09% | Akcje |
| Summit Trail Advisors, LLC | $7 043 272 | 31 658 | 0,09% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6 953 397 | 45 243 | 0,09% | Akcje |
| Corient Private Wealth LP | $6 916 838 | 31 117 | 0,09% | Akcje |
| Tredje AP-fonden | $6 780 968 | 30 479 | 0,09% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $6 656 824 | 29 921 | 0,08% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6 539 132 | 29 392 | 0,08% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 407 202 | 28 799 | 0,08% | Akcje |
| NATIONAL BANK OF CANADA /FI/ | $6 204 782 | 27 888 | 0,08% | Akcje |
| Walleye Capital LLC | $6 184 944 | 27 800 | 0,08% | Opcja kupna |
| GHP Investment Advisors, Inc. | $6 107 487 | 39 739 | 0,08% | Akcje |
| Wakefield Asset Management LLLP | $5 893 051 | 26 488 | 0,07% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $5 749 551 | 25 843 | 0,07% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $5 566 805 | 36 221 | 0,07% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $5 507 937 | 24 757 | 0,07% | Akcje |
| CWA Asset Management Group, LLC | $5 003 575 | 22 490 | 0,06% | Akcje |
| Legal & General Group Plc | $4 992 452 | 22 440 | 0,06% | Akcje |
| Mitsubishi UFJ Trust & Banking Corp | $4 942 393 | 22 215 | 0,06% | Akcje |
Insiderzy spółki 59 insiderów · 31 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 czerwca 2026 S | 840 408 | 0 | 2 | $-14 532 097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 maja 2016 S | 18 766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7 maja 2026 S | 132 434 | 0 | 1 | $-9 887 579 |
| Luis Borgen | Chief Financial Officer | 22 marca 2012 M | 18 517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 marca 2010 A | 33 604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 marca 2007 A | 31 250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1 lipca 2006 A | 10 000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 12 maja 2026 S | 94 105 | 0 | 2 | $-4 089 696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 sierpnia 2024 S | 209 365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 grudnia 2016 A | 4 688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 czerwca 2026 S | 109 194 | 0 | 2 | $-3 210 360 |
| James O Hearty | Chief Compliance Officer | 14 maja 2026 M | 22 389 | 0 | 2 | $-3 291 616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 marca 2026 A | 19 640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 marca 2023 F | 15 676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 września 2020 M | 24 590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1 czerwca 2020 F | 110 462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2 czerwca 2019 F | 33 125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 czerwca 2017 M | 3 514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 września 2015 M | 7 438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4 czerwca 2015 S | 2 322 928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 lutego 2014 M | 8 990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9 września 2013 A | — | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2 sierpnia 2013 G | 2 315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 lutego 2012 M | 17 491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 czerwca 2009 M | 5 547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 lutego 2009 M | 2 084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 sierpnia 2008 M | 2 500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5 marca 2008 A | — | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 lipca 2007 A | 6 250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8 maja 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4 listopada 2005 M | 42 000 | 0 | 0 | $0 |
| Dennis W Pullin | Dyrektor | 15 sierpnia 2026 A | 2 949 | 0 | 0 | $0 |
| Gregory J. Moore | Dyrektor | 15 sierpnia 2026 A | 8 091 | 0 | 0 | $0 |
| Jason M. Hollar | Dyrektor | 15 sierpnia 2026 A | 6 883 | 0 | 0 | $0 |
| Patricia M Arway | Dyrektor | 15 sierpnia 2026 A | 27 223 | 0 | 0 | $0 |
| Adam H Schechter | Dyrektor | 15 sierpnia 2026 A | 5 970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Dyrektor | 15 sierpnia 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Dyrektor | 15 sierpnia 2026 A | 9 803 | 0 | 0 | $0 |
| Barbara J Desoer | Dyrektor | 15 sierpnia 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Dyrektor | 15 maja 2025 A | 19 982 | 0 | 0 | $0 |
| John M Nehra | Dyrektor | 15 maja 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Dyrektor | 15 maja 2023 A | 16 069 | 0 | 0 | $0 |
| Paula A Price | Dyrektor | 15 maja 2022 A | 1 395 | 0 | 0 | $0 |
| Shawn M Guertin | Dyrektor | 15 maja 2021 A | 1 105 | 0 | 0 | $0 |
| Pascal Desroches | Dyrektor | 15 listopada 2020 A | 8 030 | 0 | 0 | $0 |
| William L Roper | Dyrektor | 11 czerwca 2020 A | 16 234 | 0 | 0 | $0 |
| Peter T Grauer | Dyrektor | 11 czerwca 2020 A | 76 204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Dyrektor | 31 grudnia 2017 A | 10 764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Dyrektor | 11 czerwca 2012 A | 7 195 | 0 | 0 | $0 |
| Richard C Vaughan | Dyrektor | 13 maja 2010 A | 6 092 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 zgłoszenia | 13 lutego 2025 | 45,00% | Aneks | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 130 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 4,50% | 217 039 NS | 30 kwietnia 2026 | N-PORT |
| AZTD · Tidal Trust I | 2,74% | 7 761 NS | 30 kwietnia 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 123 121 NS | 30 kwietnia 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,34% | 59 501 SH | 19 sierpnia 2026 | Dziennie |
| AGNG · Global X Funds | 0,92% | 3 855 NS | 31 maja 2026 | N-PORT |
| PY · Principal Exchange-Traded Funds | 0,85% | 8 414 NS | 30 czerwca 2026 | N-PORT |
| IHF · iShares Trust | 0,84% | 57 577 SH | 19 sierpnia 2026 | Dziennie |
| LSEQ · Harbor ETF Trust | 0,76% | 758 NS | 30 kwietnia 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,56% | 5 441 NS | 31 maja 2026 | N-PORT |
| BTAL · AGF Investments Trust | 0,48% | 6 072 NS | 30 czerwca 2026 | N-PORT |
| ITAN · EA Series Trust | 0,38% | 1 735 NS | 29 maja 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 10 626 NS | 30 kwietnia 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,34% | 11 220 NS | 31 maja 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9 914 SH | 19 sierpnia 2026 | Dziennie |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,30% | 2 502 NS | 31 maja 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0,30% | 352 NS | 30 kwietnia 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,23% | 4 682 NS | 30 kwietnia 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,23% | 22 912 SH | 19 sierpnia 2026 | Dziennie |
| ROSC · Lattice Strategies Trust | 0,18% | 635 NS | 30 kwietnia 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,17% | 938 128 SH | 19 sierpnia 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467 367 SH | 19 sierpnia 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,14% | 5 728 NS | 30 kwietnia 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1 975 NS | 30 kwietnia 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,14% | 124 181 NS | 30 kwietnia 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 3 564 NS | 30 kwietnia 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,12% | 90 512 NS | 31 maja 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,11% | 100 394 SH | 19 sierpnia 2026 | Dziennie |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 14 233 NS | 30 kwietnia 2026 | N-PORT |
| ISCG · iShares Trust | 0,11% | 6 082 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,10% | 17 983 NS | 30 kwietnia 2026 | N-PORT |
| ESML · iShares Trust | 0,10% | 15 920 SH | 19 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,10% | 1 555 SH | 19 sierpnia 2026 | Dziennie |
| RXL · ProShares Trust | 0,09% | 348 NS | 31 maja 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 3 622 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736 199 SH | 19 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,09% | 18 949 SH | 19 sierpnia 2026 | Dziennie |
| SMMD · iShares Trust | 0,08% | 16 434 SH | 19 sierpnia 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,07% | 667 NS | 30 kwietnia 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,07% | 3 527 SH | 19 sierpnia 2026 | Dziennie |
| IXJ · iShares Trust | 0,07% | 16 934 SH | 19 sierpnia 2026 | Dziennie |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 5 907 NS | 30 kwietnia 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,07% | 1 423 NS | 31 maja 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,07% | 930 NS | 29 maja 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,06% | 33 970 SH | 19 sierpnia 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3 190 SH | 19 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,05% | 6 930 NS | 30 kwietnia 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 1 985 SH | 19 sierpnia 2026 | Dziennie |
| IWS · iShares Trust | 0,05% | 45 622 SH | 19 sierpnia 2026 | Dziennie |
| DUHP · Dimensional ETF Trust | 0,04% | 32 462 NS | 30 kwietnia 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 381 NS | 30 kwietnia 2026 | N-PORT |